The subsequent study shows that MDM2 inhibitor Nutlin-3 induces p53 expression and leads to moderate anti-proliferative effects in p53 wildtype GIST cells (Henze et al., 2012). Here, TP53 is linked to gastrointestinal stromal tumor.